{
    "nctId": "NCT05478590",
    "briefTitle": "A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting",
    "officialTitle": "HR POSITIVE, HER 2 NEGATIVE ADVANCED BREAST CANCER- TREATMENT PATTERNS IN POLAND - HABER STUDY",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 440,
    "primaryOutcomeMeasure": "Number of Participants With HR+ HER2- Advanced Breast Cancer (ABC) Treatment Patterns",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients with histologically diagnosed advanced breast cancer (with locoregional recurrence not eligible for radical local treatment or with distant metastases)\n* Patient has a documented hormone (estrogen and/or progesterone) receptor expression and lack of HER2 receptor overexpression or lack of HER2 gene amplification (HR+/HER2- breast cancer subtype)\n* Patient had no prior treatment for advanced breast cancer\n* Patient has no symptomatic metastases to the central nervous system\n* There is no other malignancies in patient requiring active treatment\n* Patient is without co-occurring other malignancies treated with palliative assumption\n\nExclusion Criteria:\n\n* Parallel patient's participation in any other clinical trial at the time when the decision over the advanced breast cancer treatment was made or up to 30 days before it.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}